Clinical trials
Phase 2/3 Anemia, Sickle Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2012 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 3 |
| 2023 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Unknown status | 5 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 2 |
| Pfizer | 2 |
| Agios Pharmaceuticals, Inc. | 1 |
| Ain Shams University | 1 |
| Al-Neelain University | 1 |
| Beni-Suef University | 1 |
| Great Ormond Street Hospital for Children NHS Foundation Trust | 1 |
| Indiana University | 1 |
| London School of Hygiene and Tropical Medicine | 1 |
| Makerere University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia, Sickle Cell | 17 |
| Vaso-Occlusive Crises | 2 |
| beta-Thalassemia | 2 |
| Acute Chest Syndrome | 1 |
| Acute Lung Injury | 1 |
| Anemia, Diamond-Blackfan | 1 |
| Hematologic Diseases | 1 |
| Hemoglobinopathies | 1 |
| Shwachman-Diamond Syndrome | 1 |
| Sleep Apnea Syndromes | 1 |
Trials
Showing 76 to 17 of 17. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.